A woman from NSW has died after presenting a « severe form » of blood clotting in the brain « probably linked to the AstraZeneca vaccine ».
AstraZeneca COVID-19 vaccine blood clotting cause still ‘unknown’ but understanding the risk is simple….
AstraZeneca COVID-19 vaccine blood clotting cause still ‘unknown’ but understanding the risk is easy.
A 52-year-old woman from NSW has died after presenting with a « severe form » of blood clotting in the brain « probably linked to the AstraZeneca vaccine ».
The Therpaeutic Goods Administration, which monitors and reports all suspected side effects of the Covid-19 vaccine in Australia, released a report Thursday outlining the circumstances of the woman’s death.
“Since last week’s report, four more reports of blood clots and low platelets have been assessed as confirmed TTTS (thrombosis with thrombocytopenia syndrome) likely related to the AstraZeneca vaccine,” the report reads.
“One of these cases involved a 52-year-old woman from NSW who sadly died. This case presented as a severe form of this syndrome, with a blood clot in the brain known as cerebral venous sinus thrombosis.
RELATED: Victorian Wife, Husband Test Positive for Covid in Queensland
“We extend our sincere condolences to her family. New cases were also confirmed in a 77-year-old man from NSW and a 70-year-old man from South Australia. The fourth case was in an 87-year-old South Australian woman, previously reported as probable but not confirmed at that stage.
Clotting ‘extremely unhappy, extremely rare’
The TGA says it reviews all deaths reported after a vaccination is administered and compares them to expected natural death rates.
« To date, the observed number of deaths reported following vaccination is actually less than the expected number of deaths, » the TGA said in a statement.
“Every year there are about 160,000 deaths in Australia, which equates to 13,300 per month or 3,050 per week. In the most recent reporting year, two-thirds of these deaths were in people aged 75 and older.”
The regulator said last week: « apart from a single Australian case in which death was linked to TTS, Covid-19 vaccines have not been found to cause death ».
There have now been two.
Speaking to reporters this afternoon, chief physician Paul Kelly said the new blood clotting case was « extremely unfortunate », but stressed it was « extremely rare ».
“I will point out that this is only the second death, with over 3.6 million doses of this vaccine being given across Australia now, I will point out that this remains an extremely rare event to get these serious clots, but when they happen, as we have seen in this case, it can have tragic circumstances. My heart goes out to the family and all friends and colleagues of this person, » he said during Thursday afternoon’s press conference.
But he said AstraZeneca is still the recommended vaccine for people over 50 and Pfizer for under 50s.
« There’s definitely a much lower risk of this event, these clotting events, the older one gets. There’s a clear cut point there around age 50, » he said.
“(The woman’s death) is clearly concerning…but I would say this – we made those decisions based on the risk/benefit equation. Right now, the AstraZeneca is a very important part of the vaccine rollout. But nothing is mandatory. Individuals who have concerns about a medical procedure, but especially about the private vaccine at the moment, should talk to their GP about those concerns.”
In its Thursday report, the TGA cited a further « four new cases classified as probable in the past week », including three cases in NSW and one in Victoria.
A 50 year old woman and two men aged 83 and 91 presented problems in NSW and a 74 year old woman presented problems in Victoria.
“This brings the total number of Australian reports of cases assessed as TTS following the AstraZeneca vaccine to 48, with 35 confirmed cases and 13 probable cases,” the TGA reports said.
Of those, 31 have been discharged from hospital and are recovering, with some receiving ongoing outpatient medical care, and 15 remain in hospital, including one who remains critically ill in intensive care. Two people died in hospital.
A 48-year-old NSW woman died after receiving the AstraZeneca vaccine in April. The drug regulator said her death from rare blood clots was « probably » related to the vaccine.
NSW Prime Minister Gladys Berejiklian expressed her condolences to the 48-year-old woman’s family.
« We extend our heartfelt condolences to the family and loved ones at this difficult time, » she said.
The Australian Technical Advisory Group on Immunization (ATAGI) released a report last week. It noted that « 31 confirmed cases had been reported and a further 10 are considered likely in approximately 2.2 million doses of COVID-19 vaccine AstraZeneca given until May 19, 2021 ».
ATAGI estimates the risk of TTS in Australia to be about 3.1 per 100,000 for those over 50 and 1.8 per 100,000 for those under 50.
#NSW #woman #dead #linked #AstraZeneca #vaccine